Superstring Capital Management »

Keros Therapeutics shares owned by Superstring Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Superstring Capital Management from 13F filings

Historical chart of Superstring Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Superstring Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Superstring Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 75k 39.76